These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 1848636

  • 21. Polymorphic metabolism of metoprolol: clinical studies.
    Silas JH, McGourty JC, Lennard MS, Tucker GT, Woods HF.
    Eur J Clin Pharmacol; 1985; 28 Suppl():85-8. PubMed ID: 4054194
    [Abstract] [Full Text] [Related]

  • 22. Influence of chronic renal failure on stereoselective metoprolol metabolism in hypertensive patients.
    Cerqueira PM, Coelho EB, Geleilete TJ, Goldman GH, Lanchote VL.
    J Clin Pharmacol; 2005 Dec; 45(12):1422-33. PubMed ID: 16291718
    [Abstract] [Full Text] [Related]

  • 23. The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations.
    Lennard MS, Tucker GT, Woods HF.
    Clin Pharmacokinet; 1986 Dec; 11(1):1-17. PubMed ID: 2868819
    [Abstract] [Full Text] [Related]

  • 24. Enantiospecific pharmacokinetics of metoprolol in CYP2D6 ultra-rapid metabolizers and correlation with exercise-induced heart rate.
    Seeringer A, Brockmöller J, Bauer S, Kirchheiner J.
    Eur J Clin Pharmacol; 2008 Sep; 64(9):883-8. PubMed ID: 18545991
    [Abstract] [Full Text] [Related]

  • 25. Rapid chiral separation of metoprolol in plasma--application to the pharmacokinetics/pharmacodynamics of metoprolol enantiomers in the conscious goat.
    Leloux MS.
    Biomed Chromatogr; 1992 Sep; 6(2):99-105. PubMed ID: 1638099
    [Abstract] [Full Text] [Related]

  • 26. Toward optimal treatment in women: the effect of sex on metoprolol-diphenhydramine interaction.
    Sharma A, Pibarot P, Pilote S, Dumesnil JG, Arsenault M, Bélanger PM, Meibohm B, Hamelin BA.
    J Clin Pharmacol; 2010 Feb; 50(2):214-25. PubMed ID: 19948945
    [Abstract] [Full Text] [Related]

  • 27. Stereoselective disposition of flecainide in relation to the sparteine/debrisoquine metaboliser phenotype.
    Gross AS, Mikus G, Fischer C, Hertrampf R, Gundert-Remy U, Eichelbaum M.
    Br J Clin Pharmacol; 1989 Nov; 28(5):555-66. PubMed ID: 2511912
    [Abstract] [Full Text] [Related]

  • 28. The racemic metoprolol H2-antagonist interaction.
    Toon S, Davidson EM, Garstang FM, Batra H, Bowes RJ, Rowland M.
    Clin Pharmacol Ther; 1988 Mar; 43(3):283-9. PubMed ID: 3345620
    [Abstract] [Full Text] [Related]

  • 29. Debrisoquine polymorphism and the metabolism and action of metoprolol, timolol, propranolol and atenolol.
    Lennard MS, Tucker GT, Silas JH, Woods HF.
    Xenobiotica; 1986 May; 16(5):435-47. PubMed ID: 2874665
    [Abstract] [Full Text] [Related]

  • 30. Defective metabolism of metoprolol in poor hydroxylators of debrisoquine.
    Lennard MS, Silas JH, Freestone S, Trevethick J.
    Br J Clin Pharmacol; 1982 Aug; 14(2):301-3. PubMed ID: 6125207
    [Abstract] [Full Text] [Related]

  • 31. Modeling of the effect site equilibration kinetics and pharmacodynamics of racemic baclofen and its enantiomers using quantitative EEG effect measures.
    Mandema JW, Heijligers-Feijen CD, Tukker E, De Boer AG, Danhof M.
    J Pharmacol Exp Ther; 1992 Apr; 261(1):88-95. PubMed ID: 1560387
    [Abstract] [Full Text] [Related]

  • 32. Stereoselective analysis of metoprolol and its metabolites in rat plasma with application to oxidative metabolism.
    Boralli VB, Coelho EB, Cerqueira PM, Lanchote VL.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep 05; 823(2):195-202. PubMed ID: 16029965
    [Abstract] [Full Text] [Related]

  • 33. Influence of CYP2D6-dependent metabolism on the steady-state pharmacokinetics and pharmacodynamics of metoprolol and nicardipine, alone and in combination.
    Laurent-Kenesi MA, Funck-Brentano C, Poirier JM, Decolin D, Jaillon P.
    Br J Clin Pharmacol; 1993 Dec 05; 36(6):531-8. PubMed ID: 12959269
    [Abstract] [Full Text] [Related]

  • 34. Controlled-release metoprolol compared with atenolol in asthmatic patients: interaction with terbutaline.
    Löfdahl CG, Dahlöf C, Westergren G, Olofsson B, Svedmyr N.
    Eur J Clin Pharmacol; 1988 Dec 05; 33 Suppl():S25-32. PubMed ID: 2836204
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics of bambuterol in subjects homozygous for the atypical gene for plasma cholinesterase.
    Bang U, Nyberg L, Rosenborg J, Viby-Mogensen J.
    Br J Clin Pharmacol; 1998 May 05; 45(5):479-84. PubMed ID: 9643621
    [Abstract] [Full Text] [Related]

  • 36. Is metoprolol CR/ZOK more selective than conventional metoprolol and atenolol?
    Kendall M, Akhlaghi S, Hughes B, Lewis H.
    J Clin Pharmacol; 1990 Feb 05; 30(S2):S98-102. PubMed ID: 2155948
    [Abstract] [Full Text] [Related]

  • 37. Metabolic ratios of four probes of CYP2D6 in Turkish subjects: a cross-over study.
    Bozkurt A, Basçi NE, Işimer A, Sayal A, Kayaalp SO.
    Eur J Drug Metab Pharmacokinet; 1996 Feb 05; 21(4):309-14. PubMed ID: 9074895
    [Abstract] [Full Text] [Related]

  • 38. Polymorphic flecainide disposition under conditions of uncontrolled urine flow and pH.
    Gross AS, Mikus G, Fischer C, Eichelbaum M.
    Eur J Clin Pharmacol; 1991 Feb 05; 40(2):155-62. PubMed ID: 1906003
    [Abstract] [Full Text] [Related]

  • 39. Interindividual variation of beta-adrenoceptor blocking drugs, plasma concentration and effect: influence of genetic status on behaviour of atenolol, bopindolol and metoprolol.
    Dayer P, Leemann T, Marmy A, Rosenthaler J.
    Eur J Clin Pharmacol; 1985 Feb 05; 28(2):149-53. PubMed ID: 2859203
    [Abstract] [Full Text] [Related]

  • 40. Evidence for a dissociation in the control of sparteine, debrisoquine and metoprolol metabolism in Nigerians.
    Lennard MS, Iyun AO, Jackson PR, Tucker GT, Woods HF.
    Pharmacogenetics; 1992 Apr 05; 2(2):89-92. PubMed ID: 1302046
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.